Your (or your loved one’s) medical records contain clues that can lead to new treatments.
AllStripes researchers learn from patient records what would truly improve quality of life.
Using cutting-edge tech we analyze your community’s data to improve trial design and chances of success.
Your community’s de-identified records can advance multiple treatment studies.
We do the work to collect all your records, at no cost, in your secure account. Access doctors’ notes you’ve never seen.
See how your rare disease journey compares to others with your condition, and what’s helping.
We’ll send you exclusive updates on the studies you’re contributing to and how you’re driving forward research.
CCM3 syndrome is a genetic condition characterized by the development of abnormal mulberry-shaped blood vessels in the brain and spinal cord. These leaky blood vessels, called cavernous angiomas (CCAs), lead to an increased risk of seizures and cerebral hemorrhage. CCM3 syndrome also increases risk of benign brain tumors and scoliosis. Onset of symptoms can occur in childhood or adulthood. CCM3 syndrome is caused by DNA changes in the gene PDCD10 (also known as CCM3), which is thought to play a role in a variety of functions, including the formation and integrity of blood vessel walls and the gut lining. Current treatment is aimed at easing symptoms of the condition or surgically removing the abnormal blood vessels.
The latest on our research: We are jumpstarting our CCM3 syndrome program in partnership with the Angioma Alliance to accelerate research for the condition. We welcome all patients and caregivers interested in participating and spreading the word to the CCM3 syndrome community.
1. Sign up
Create your private account and review our research consent (takes about 10 minutes)
2. We get to work
We do all the behind-the-scenes work to retrieve and process your records
3. Impact research
Power multiple research projects at once by contributing your de-identified data
We believe that the only way to keep data accessible to the researchers who need it is by enabling patients to own and control their own data. Patients decide for themselves whether they want to privately and securely contribute to research, rather than having the decision made on their behalf.
We aim to make useful data accessible to all researchers who have legitimate research questions or research programs. For academic research, we offer access without charge. We take research ethics seriously, and we have policies in place to ensure that research is conducted with integrity.
We don’t like to take sides—we give all members of the community the option to get involved. Success in rare disease research takes a village and we always welcome additional collaborators who can advance and benefit from the mission.
Our primary mission is to accelerate drug development, so we prioritize generating insights specifically relevant to therapeutic research. We invest deeply in quality, security, and compliance to make this a reality.